AMBEV S.A. current report, Q4 FY2018

Business Context and Reporting Period

This Form 6-K filing by AMBEV S.A. covers the period from November 1 to November 30, 2018. The report details consolidated transactions of securities and derivatives involving the company's Board of Directors, Management, and related persons, in compliance with Article 11 of CVM Instruction # 358/2002. The filing was signed on December 10, 2018.

Key Financial Metrics

The filing text does not provide company-wide financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on insider trading activity.

Group Transaction Type Quantity Volume (BRL)
Board of Directors Sell (Common Shares) 1,190 R$ 19,873.88
Group and Related Persons Buy (Common Shares via Lending Settlement) 190,000 N/A
Group and Related Persons Buy (Deferred ADRs) 34,384 R$ 53,982.88
Management No Activity 0 0

Material Changes

The filing does not provide comparative data against prior periods to determine material changes in financial performance. Regarding securities holdings:

  • Board of Directors: Reduced common share holdings from 5,618,231 to 5,617,041 following sales.
  • Group and Related Persons: Increased common share holdings from 34,051,768 to 34,241,768 and ADR holdings from 1,915,501 to 1,949,885. Securities lending positions were settled, reducing that balance to zero.
  • Management: No change in holdings; balance remained at 7,225 common shares.

Guidance, Outlook, and Risks

The filing text does not contain management commentary, financial guidance, outlook, risk factors, or contingencies. It is a regulatory disclosure of specific insider transactions.

Investor Verification Checklist

  • Verify the aggregate impact of the 1,190 shares sold by the Board of Directors against total outstanding shares.
  • Confirm the nature of the 190,000 shares acquired by the Group via "Settlement of Securities Lending" to ensure no cash outflow occurred for this portion.
  • Review the price of R$ 1.57 for Deferred ADRs to understand the valuation context relative to the market price of common shares (approx. R$ 16.70).
  • Check subsequent filings for any changes in the securities lending maturity date (originally August 8, 2019).